PATENT CLAIM ANALYSIS

Application Number: 16356172
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "210160"]

Abstract:
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

Claim (Index 46):
The method of  claim 43 , wherein the compound is

Metadata:
- Claim Count in Document: 65.0
- Percentile: 99.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15770256', '15770255', '15549465', '14421057', '14421062']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7875035272558236
- 35 USC 102 Novelty (BERT): 0.5701533994405543
- Combined Prediction Score: 0.7657685144742966
- Mean Citation Score: 405.479048
- Max Citation Score: 474.67447
- Similarity Product: 336.1875360790968

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test